XML 42 R25.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Segment Reporting (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2018
Segment Reporting |
Reconciliation of the Company's business segments to the consolidated financial statements |
|  | Pharmacy |  |  |  |  |  |  |  |  |  |  |  |
|  | Services |  | Retail/LTC |  | Corporate |  | Intersegment |  | Consolidated
In millions |  | Segment |  | Segment |  | Segment |  | Eliminations |  | Totals
Cost of revenues, as previously reported |  | $ | 30,127 |  | $ | 13,665 |  |  |  |  | $ | (5,858) |  | $ | 37,934
Adjustments |  |  | 14 |  |  | (5) |  |  |  |  |  | — |  |  | 9
Cost of revenues, as adjusted |  | $ | 30,141 |  | $ | 13,660 |  |  |  |  | $ | (5,858) |  | $ | 37,943
Gross profit, as previously reported |  | $ | 1,096 |  | $ | 5,676 |  |  |  |  | $ | (192) |  | $ | 6,580
Adjustments |  |  | (14) |  |  | 5 |  |  |  |  |  | — |  |  | (9)
Gross profit, as adjusted |  | $ | 1,082 |  | $ | 5,681 |  |  |  |  | $ | (192) |  | $ | 6,571
Operating expenses, as previously reported |  | $ | 312 |  | $ | 4,265 |  | $ | 226 |  | $ | (16) |  | $ | 4,787
Adjustments |  |  | 13 |  |  | (17) |  |  | (5) |  |  | — |  |  | (9)
Operating expenses, as adjusted |  | $ | 325 |  | $ | 4,248 |  | $ | 221 |  | $ | (16) |  | $ | 4,778
Operating profit (loss), as previously reported |  | $ | 784 |  | $ | 1,411 |  | $ | (226) |  | $ | (176) |  | $ | 1,793
Adjustments |  |  | (27) |  |  | 22 |  |  | 5 |  |  | — |  |  | —
Operating profit (loss), as adjusted |  | $ | 757 |  | $ | 1,433 |  | $ | (221) |  | $ | (176) |  | $ | 1,793
The following is a reconciliation of the Company’s segments to the accompanying condensed consolidated financial statements:
|  | Pharmacy |  |  |  |  |  |  |  |  |  |  |  |
|  | Services |  | Retail/LTC |  | Corporate |  | Intersegment |  | Consolidated
In millions |  | Segment(1) |  | Segment |  | Segment |  | Eliminations(2) |  | Totals
Three Months Ended |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
March 31, 2018: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net revenues |  | $ | 32,218 |  | $ | 20,432 |  | $ | — |  | $ | (6,957) |  | $ | 45,693
Gross profit |  |  | 1,138 |  |  | 5,916 |  |  | — |  |  | (195) |  |  | 6,859
Operating profit (loss) (3)(4) |  |  | 761 |  |  | 1,624 |  |  | (264) |  |  | (175) |  |  | 1,946
March 31, 2017: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  | 31,223 |  |  | 19,341 |  |  | — |  |  | (6,050) |  |  | 44,514
Gross profit |  |  | 1,082 |  |  | 5,681 |  |  | — |  |  | (192) |  |  | 6,571
Operating profit (loss) (5) |  |  | 757 |  |  | 1,433 |  |  | (221) |  |  | (176) |  |  | 1,793
| (1) |  | Net revenues of the Pharmacy Services Segment include approximately $3.3 billion and $3.1 billion of retail co‑payments for the three months ended March 31, 2018 and 2017, respectively.
| (2) |  | Intersegment eliminations relate to intersegment revenue generating activities that occur between the Pharmacy Services Segment and the Retail/LTC Segment. These occur in the following ways: when members of Pharmacy Services Segment clients (“members”) fill prescriptions at the Company’s retail pharmacies to purchase covered products, when members enrolled in programs such as Maintenance Choice® elect to pick up maintenance prescriptions at one of the Company’s retail pharmacies instead of receiving them through the mail, or when members have prescriptions filled at the Company’s long-term care pharmacies. When these occur, both the Pharmacy Services and Retail/LTC segments record the revenues, gross profit and operating profit on a standalone basis.
| (3) |  | The Retail/LTC Segment operating profit for the three months ended March 31, 2018 includes an $86 million loss on the divestiture of the RxCrossroads subsidiary (see “Note 3 – Goodwill” to the condensed consolidated financial statements) and $3 million of acquisition-related integration costs related to the acquisition of Omnicare.
| (4) |  | The Corporate Segment operating loss for the three months ended March 31, 2018 includes $40 million in acquisition-related transaction and integration costs related to the proposed Aetna acquisition.
The Retail/LTC Segment operating profit for the three months ended March 31, 2017 includes a $199 million charge associated with store closures and $15 million of acquisition-related integration costs related to the acquisition of Omnicare.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8813-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8736-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration